Siobhan F. Cross
Christchurch, CAN, New Zealand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Mapping Childhood Cancer Care Services in Oceania: Methodological Lessons From the SIOP Global Mapping Programme.
Journal: Pediatric blood & cancer
Published: April 09, 2026
Tracking Health Related Quality of Life From Diagnosis to Follow-Up Among Australian Children With Acute Lymphoblastic Leukaemia.
Journal: Pediatric blood & cancer
Published: December 18, 2025
Optimising Asparaginase Use and Managing Hypersensitivity in Australasia-A Clinical Practice Guideline From the Australian and New Zealand Children's Haematology/Oncology Group.
Journal: Journal of paediatrics and child health
Published: December 15, 2025
Psychosocial Outcomes in Parents of Children with Acute Lymphoblastic Leukaemia in Australia and New Zealand Through and Beyond Treatment.
Journal: Cancers
Published: February 03, 2025
Clinical and genetic spectrum of Fanconi anemia in Australia and New Zealand.
Journal: Genetics in medicine open
Published: December 05, 2024
Late effects in survivors of infant acute lymphoblastic leukaemia-a study of the Australian and New Zealand Children's Haematology/Oncology Group.
Journal: Blood cancer journal
Published: July 25, 2023
Childhood cancer incidence & survival in Aotearoa, New Zealand 2010-2019.
Journal: Cancer epidemiology
Published: May 15, 2023
Paediatric Central Nervous System Tumours: Symptomatology and Total Diagnostic Interval in a New Zealand Cohort.
Journal: Journal of paediatrics and child health
Published: May 07, 2023
Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions.
Journal: British journal of cancer
Published: September 17, 2021
Malignant Melanoma in Children and Adolescents Treated in Pediatric Oncology Centers: An Australian and New Zealand Children's Oncology Group (ANZCHOG) Study.
Journal: Frontiers in oncology
Published: January 28, 2021
Outcomes for Australian children with relapsed/refractory acute lymphoblastic leukaemia treated with blinatumomab.
Journal: Pediatric blood & cancer
Published: November 18, 2020
Last Updated: 09/26/2026